// App-Quantinova.ai

THU0096 : REVISITING THE REMISSION CRITERIA FOR RHEUMATOID ARTHRITIS BY EXCLUDING PATIENT GLOBAL ASSESSMENT: AN INDIVIDUAL PATIENT META-ANALYSIS INCLUDING 5792 PATIENTS

Researchers

Presenter

  • R. J. O. Ferreira

Principal Investigators

  • P. Welsing

  • J. W. G. Jacobs

  • L. Gossec

  • M. Ndosi

  • P. Machado

  • D. Van der Heijde

  • J. A. P. Da Silva

Medical Centers

  • CHUC, Rheumatology, Coimbra, Portugal

  • ESEnfC, UICISA:E, Coimbra, Portugal

  • UMC Utrecht, Dept. of Rheumatology and Clinical Immunology, Utrecht, Netherlands

  • Sorbone University, INSERM UMRS1155, Paris, France

  • Pitié-Salpêtrière Hospital, APHP, Rheumatology, Paris, France

  • UWE, Nursing and Midwifery, Bristol, United Kingdom

  • UCL, Centre for Rheumatology & MRC Centre for Neuromuscular Diseases, London, United Kingdom

  • LUMC, Radiology, Leiden, Netherlands

  • University of Lisbon, Faculty of Medicine, Lisboa, Portugal

Locations

  • Portugal

  • Netherlands

  • France

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • C reactive protein

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved